Upgrade to SI Premium - Free Trial

CorMedix (CRMD)

8.92 +0.15 (1.71%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 8-K CorMedix Inc. For: Jun 08 June 8, 2026 8:45 AM - SEC Filing CorMedix wins federal appeals court ruling on Minocin patent case June 8, 2026 8:32 AM - StreetInsider U.S. Court of Appeals for the Federal Circuit Affirms Victory for Cormedix Therapeutics in Minocin® Patent Litigation June 8, 2026 8:30 AM - Globe NewsWire Form SCHEDULE 13G/A CorMedix Inc. Filed by: Deep Track Capital, LP May 15, 2026 8:40 AM - SEC Filing Cormedix Therapeutics to Participate in two Upcoming Investor Conferences May 15, 2026 8:30 AM - Globe NewsWire Form 10-Q CorMedix Inc. For: Mar 31 May 14, 2026 8:00 AM - SEC Filing Form 8-K CorMedix Inc. For: May 14 May 14, 2026 7:35 AM - SEC Filing CorMedix (CRMD) Misses Q1 EPS by 2c l Offers Guidance May 14, 2026 7:35 AM - StreetInsider Cormedix Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update May 14, 2026 7:30 AM - Globe NewsWire CorMedix Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 14, 2026 May 5, 2026 8:30 AM - Globe NewsWire Form ARS CorMedix Inc. For: Dec 31 April 29, 2026 4:22 PM - SEC Filing Form DEFA14A CorMedix Inc. April 29, 2026 4:20 PM - SEC Filing Form DEF 14A CorMedix Inc. For: Jun 23 April 29, 2026 4:19 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on CorMedix (CRMD) April 28, 2026 6:45 AM - StreetInsider CorMedix (CRMD) Reiterated at Market Outperform by Citizens on Positive REZZAYO Results April 28, 2026 4:18 AM - StreetInsider CorMedix (CRMD) PT Raised to $14 at RBC Capital April 27, 2026 1:20 PM - StreetInsider Form 8-K CorMedix Inc. For: Apr 27 April 27, 2026 8:05 AM - SEC Filing CorMedix reports positive Phase III trial results for REZZAYO fungal prophylaxis April 27, 2026 7:30 AM - StreetInsider CorMedix Therapeutics Announces Positive Topline Results from Phase III ReSPECT Trial Assessing REZZAYO® for the Prophylaxis of Invasive Fungal Diseases in Allogeneic Hematopoietic Stem Cell Transpla April 27, 2026 7:30 AM - Globe NewsWire Form PRE 14A CorMedix Inc. For: Apr 17 April 17, 2026 4:16 PM - SEC Filing CorMedix to Participate in Needham Virtual Healthcare Conference April 7, 2026 12:47 PM - Globe NewsWire Form SCHEDULE 13G/A CorMedix Inc. Filed by: VANGUARD GROUP INC March 26, 2026 5:49 PM - SEC Filing Full Article List